Podcasts

In 2019, the FDA updated requirements for bacterial mitigation strategies, which will result in significant changes to how platelets are manufactured, explains Alexis Peedin, MD, FCAP, in this CAPcast interview.

In a recent panel discussion, pathologists talked about the implications of patients who postponed their care because of the pandemic, the potential issues laboratories could face as they return to seek treatment, and what roles pathologists will have in patient care as we move past the pandemic.

In this CAPcast, Digital Content Committee Chair Michael Misialek, MD, FCAP, leads a discussion about ongoing professional practice evaluation (OPPE) and focused professional practice evaluation (FPPE).

In this CAPcast, Duke Medical Center pathology resident Dr. Richard Davis interviews leading pathology informatics expert Dr. Raj Dash about biobanking and its integration with various LIS technologies.

In this CAPcast we are joined by Joe Saad, MD, FCAP, vice chair of the Council on Government and Professional Affairs, and Walter Klein, MD, FCAP, who has participated in virtual lobbying meetings with his members of Congress and has attended previous CAP Hill Days. They will get into greater detail and give pathologists tips on how to conduct a virtual meeting with a senator or representative in Congress.

Absolute Eosinophilia: A Practical Approach is the latest activity from the CAP’s Clinical Pathology Improvement Program (CPIP). This activity describes a pragmatic approach for the workup of eosinophilia, including the appropriate application of molecular genetic studies, explains one of the CPIP case authors, Vandita Johari, MD, FCAP, in this CAPcast interview.

In this CAPcast episode, Yale Pathology’s Dhanpat Jain, MD, FCAP, discusses how cancer protocols benefit his practice, particularly the protocol that guides the diagnosis of esophagus-related cancers.

The CAP's Advocacy efforts have included several touchpoints with the Administration and Congress. In this CAPcast, Jonathan Myles, MD, FCAP, will discuss the CAP’s actions this year to influence the government’s response to the pandemic.

This CAPcast interview features the audio recording of a recent CAP Zoom media briefing, 'The Rapidly Changing COVID-19 Testing Landscape: Vaccines, Variants, and Health Disparities.'

Some biomarkers are already covered in what has become routine testing in many laboratories, affording pathologists an opportunity to play a central role in developing and implementing these biomarkers in ways to improve patient care, explains Eric Walk, MD, FCAP, Chief Medical & Scientific Officer and Senior VP of Medical & Scientific Affairs with Roche Diagnostics, in this CAPcast.

In this CAPcast, Gary Horowitz, MD, FCAP, Chair of the CAP’s Accuracy-Based Programs Committee, explains why it’s important to incorporate accuracy-based testing into your quality process.

Surveys have shown hesitancy among African Americans to take the COVID-19 vaccine, much to the concern of physicians and public health experts, who emphasize the perils posed by immunization gaps in certain populations to overall public health.

In this CAPcast interview, Tim Aukerman, Corporate Quality Assessment Manager at Quest Diagnostics, discusses his experience with directly transmitting PT results to the CAP via the Data Innovations Instrument Manager.

There are several methods for workup of urinary tract infections or UTIs and utilizing the appropriate test(s) on the appropriate patients can allow for prompt and appropriate treatment and symptom relief, as well as reduce unnecessary testing and unnecessary treatment with antimicrobials, explains Dr. Stacy Beal, in this CAPcast.

In this CAPcast, Dr. Vaught discusses the special challenges involved in developing protocols to work with biospecimens collected from patients during an infectious disease emergency, as well as the role that biobanks play in the development of COVID vaccines and therapies.

In this CAPcast interview, Dr. Thomas Wheeler discusses the survey’s findings, which confirm the pandemic's ongoing adverse effects on pathologists as the United States has relied on COVID-19 testing throughout this national crisis.

Introducing a new antigen proficiency testing program for SARS-CoV-2 virus to complement existing programs for molecular and serology PT, the CAP now offers laboratories a complete suite of PT and quality improvement programs for all COVID-19-related testing.

To meet the demand for SARS-CoV-2 molecular testing, many laboratories have expanded testing capacity by adding multiple molecular instruments. However, this has left laboratories with questions regarding proficiency testing (PT) requirements for these additional instruments, as two CAP members, Dr. Bobbi Pritt and Dr. Lauren Pearson, explain in this CAPcast interview.

Regularly published research findings seem to question the validity or efficacy of many of the testing methods – and PCR is no different, as Dr. Sophia Yohe explains in this CAPcast interview.

In this interview, Dr. Duong will discuss what pathologists need to know during this important transition, and important tips to gain confidence when you first start out in practice.